KANGSTEM BIOTECH Co., Ltd. engages in the manufacture, development, and sale of stem cell therapy products. Its services include next generation and gene-loaded stem cell. The company was founded by Kyung-Sun Kang on October 29, 2010 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company